newsfilter
← Latest News
GlobeNewswire·

InflaRx to Report Second Quarter 2025 Results on August 7, 2025

JENA, Germany, July 31, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (NASDAQ:IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company